Position history for CITADEL ADVISORS LLC's holdings in ORAMED PHARMACEUTICALS INC
CITADEL ADVISORS LLC holds 98,629 shares of ORMP (ORAMED PHARMACEUTICALS INC), worth $335,338 as of 2026-Q1. The position was decreased (-49.7% shares). ORMP represents 0.0% of CITADEL ADVISORS LLC's portfolio.
Current Value
$335,338
Current Shares
98,629
Total Value Change
+$283,117
Total Shares Change
+77,227
Other major holders of ORMP: BNP PARIBAS FINANCIAL MARKETS, Steward Partners Investment Advisory, LLC, Invesco Ltd.
Decreased |
| 98,629 |
-49.7% |
| $335,338 |
| 0.0% |
| $3.38 |
0 |
| 2025-Q4 | Increased | 196,020 | +75.5% | $558,657 | 0.0% | $2.62 | 37 |
| 2025-Q3 | Increased | 111,707 | +27.9% | $294,906 | 0.0% | $2.52 | 20 |
| 2025-Q2 | Increased | 87,316 | +2645x | $196,461 | 0.0% | $2.00 | 25 |
| 2025-Q1 | Decreased | 33 | -100.0% | $71 | 0.0% | $2.06 | 0 |
| 2024-Q4 | Increased | 72,489 | +238.7% | $175,424 | 0.0% | $2.17 | 25 |
| 2024-Q3 | New | 21,402 | - | $52,221 | 0.0% | $2.31 | 32 |